4.7 Letter

Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6

期刊

CLINICAL MICROBIOLOGY AND INFECTION
卷 22, 期 10, 页码 893-895

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.cmi.2016.07.006

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

PEG-Asparaginase Single-Agent Rescue in an Advanced Case of Monomorphic Epitheliotropic Intestinal T Cell Lymphoma

Emiliano Barbieri, Stefano Pozzi, Roberta Gelmini, Luca Roncati, Monica Maccaferri, Leonardo Potenza, Roberto Marasca, Mario Luppi, Giovanna Leonardi

Summary: This case report provides new evidence on the effectiveness of PEG-asparaginase therapy in MEITL patients. However, the high toxicity of this treatment should be taken into consideration.

JOURNAL OF GASTROINTESTINAL CANCER (2023)

Letter Hematology

Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience

Stefano Cordella, Angelica Parisotto, Francesca Bettelli, Monica Morselli, Emiliano Barbieri, Stefano Pozzi, Anna Aquilino, Gianluca Repaci, Angela Cuoghi, Paola Bresciani, Andrea Messerotti, Corrado Colasante, Andrea Gilioli, Valeria Pioli, Davide Giusti, Elisabetta Colaci, Luca Cassanelli, Giovanni Ceccherelli, Mirco Bevini, Roberta Malavolti, Donatella Venturelli, Ambra Paolini, Silvia Martinelli, Rossana Maffei, Giovanni Riva, Vincenzo Nasillo, Tommaso Trenti, Patrizia Comoli, Enrico Tagliafico, Rossella Manfredini, Patrizia Barozzi, Leonardo Potenza, Roberto Marasca, Mario Luppi, Fabio Forghieri

ANNALS OF HEMATOLOGY (2023)

Article Oncology

Effects of the BTN162b2 mRNA COVID-19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia

Stefania Fiorcari, Claudio Giacinto Atene, Rossana Maffei, Nicolo Mesini, Giulia Debbia, Corrado Colasante, Stefano Pozzi, Emiliano Barbieri, Monica Maccaferri, Giovanna Leonardi, Leonardo Potenza, Mario Luppi, Roberto Marasca

Summary: Patients with chronic lymphocytic leukemia (CLL) have a reduced immune response to the SARS-CoV-2 vaccine, particularly those under treatment with ibrutinib. Therefore, it is necessary to optimize the vaccination strategy and strengthen preventive measures against COVID-19 in CLL patients.

HEMATOLOGICAL ONCOLOGY (2023)

Article Oncology

Perceptions of Death Among Patients with Advanced Cancer Receiving Early Palliative Care and Their Caregivers: Results from a Mixed-Method Analysis

Sarah Bigi, Vittorio Ganfi, Eleonora Borelli, Leonardo Potenza, Fabrizio Artioli, Sonia Eliardo, Claudia Mucciarini, Luca Cottafavi, Umberto Ferrari, Laura Lombardo, Katia Cagossi, Alessandra Pietramaggiori, Valeria Fantuzzi, Ilaria Bernardini, Massimiliano Cruciani, Cristina Cacciari, Oreofe Odejide, Carlo Adolfo Porro, Camilla Zimmermann, Fabio Efficace, Eduardo Bruera, Mario Luppi, Elena Bandieri

Summary: Early palliative care interventions can increase the acceptance of death in patients with advanced cancer and their caregivers, with the EPC group showing a more positive attitude towards death.

ONCOLOGIST (2023)

Article Andrology

Determinants of sexual function in men living with HIV younger than 50 years old: Focus on organic, relational, and psychological issues

Sara De Vincentis, Maria Chiara Decaroli, Jovana Milic, Flaminia Fanelli, Giulia Tartaro, Chiara Diazzi, Marco Mezzullo, Maria Cristina De Santis, Laura Roli, Tommaso Trenti, Daniele Santi, Uberto Pagotto, Giovanni Guaraldi, Vincenzo Rochira

Summary: This study investigates the impact of risk factors for sexual dysfunctions, including organic, relational, and psychological components, on erectile function in men living with HIV aged under 50. The results show that psychological factors are predominant in men living with HIV, rather than gonadal status and other classical risk factors.

ANDROLOGY (2023)

Article Oncology

Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies

Ivana Lagreca, Vincenzo Nasillo, Patrizia Barozzi, Ilaria Castelli, Sabrina Basso, Sara Castellano, Ambra Paolini, Monica Maccaferri, Elisabetta Colaci, Daniela Vallerini, Patrizia Natali, Daria Debbia, Tommaso Pirotti, Anna Maria Ottomano, Rossana Maffei, Francesca Bettelli, Davide Giusti, Andrea Messerotti, Andrea Gilioli, Valeria Pioli, Giovanna Leonardi, Fabio Forghieri, Paola Bresciani, Angela Cuoghi, Monica Morselli, Rossella Manfredini, Giuseppe Longo, Anna Candoni, Roberto Marasca, Leonardo Potenza, Enrico Tagliafico, Tommaso Trenti, Patrizia Comoli, Mario Luppi, Giovanni Riva

Summary: This study sheds light on the dynamics of MM-specific T cells in patients with MGUS/SMM and introduces a new prognostic tool called MaMs T-cell assay, which may serve as an immunologic marker for effective disease control. The findings suggest that this assay can be routinely applied for risk assessment and prognostic evaluation in patients with monoclonal gammopathies.

CANCERS (2023)

Review Oncology

Role of Notch2 pathway in mature B cell malignancies

Nicolo Mesini, Stefania Fiorcari, Claudio Giacinto Atene, Rossana Maffei, Leonardo Potenza, Mario Luppi, Roberto Marasca

Summary: In recent decades, the Notch pathway has been recognized as an important regulatory signaling in cell-fate decisions and its alteration has been linked to tumor genesis and progression. The focus of this review is on the activity of Notch2 receptor, which has been found to be mutated in CLL, SMZL, and NMZL. A better understanding of the pathogenic role of Notch2 and the development of targeted therapies are desired.

FRONTIERS IN ONCOLOGY (2023)

Article Oncology

Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model

Elisa Bianchi, Sebastiano Rontauroli, Lara Tavernari, Margherita Mirabile, Francesca Pedrazzi, Elena Genovese, Stefano Sartini, Massimiliano Dall'Ora, Giulia Grisendi, Luca Fabbiani, Monica Maccaferri, Chiara Carretta, Sandra Parenti, Sebastian Fantini, Niccolo Bartalucci, Laura Calabresi, Manjola Balliu, Paola Guglielmelli, Leonardo Potenza, Enrico Tagliafico, Lorena Losi, Massimo Dominici, Mario Luppi, Alessandro Maria Vannucchi, Rossella Manfredini

Summary: BM fibrosis is a major pathology in myelofibrosis and is associated with overexpression of OPN protein. ERK1/2 is a key regulator of OPN production, and inhibiting ERK1/2 activity can reduce OPN production and hinder the development of BM fibrosis. Targeting OPN and ERK1/2 could be potential therapeutic strategies for myelofibrosis.

LEUKEMIA (2023)

Article Oncology

Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia

Marica De Cicco, Ivana Lagreca, Sabrina Basso, Patrizia Barozzi, Stella Muscianisi, Alba Bianco, Giovanni Riva, Sara Di Vincenzo, Chiara Pulvirenti, Davide Sapuppo, Mariangela Siciliano, Vittorio Rosti, Anna Candoni, Marco Zecca, Fabio Forghieri, Mario Luppi, Patrizia Comoli

Summary: This study investigated the feasibility of producing mutated-NPM1-specific cytotoxic T cells (CTLs) for the treatment of NPM1-mutated AML patients. The results showed that mutated-NPM1-specific CTLs with specific cytokine production and high cytotoxicity against patients' leukemia cells could be obtained from both patients and donors. These polyfunctional mutated-NPM1-specific CTLs included both CD8+ and CD4+ T cells with strong lytic capacity.

CANCERS (2023)

Article Public, Environmental & Occupational Health

Early palliative care for solid and blood cancer patients and caregivers: Quantitative and qualitative results of a long-term experience as a case of value-based medicine

Sarah Bigi, Eleonora Borelli, Leonardo Potenza, Fabio Gilioli, Fabrizio Artioli, Giampiero Porzio, Mario Luppi, Elena Bandieri

Summary: Cancer patients and their caregivers have unmet needs. Integrating early palliative care into standard oncologic care has been recognized as an effective model to address these needs. The key elements of this model include multidisciplinary collaboration, honest communication, and constant monitoring of patients' wellbeing.

FRONTIERS IN PUBLIC HEALTH (2023)

Review Medicine, Research & Experimental

The dynamic functions of IRF4 in B cell malignancies

Rossana Maffei, Stefania Fiorcari, Claudio Giacinto Atene, Silvia Martinelli, Nicolo Mesini, Flora Pilato, Ivana Lagreca, Patrizia Barozzi, Giovanni Riva, Vincenzo Nasillo, Ambra Paolini, Fabio Forghieri, Leonardo Potenza, Tommaso Trenti, Enrico Tagliafico, Mario Luppi, Roberto Marasca

Summary: Interferon regulatory factor 4 (IRF4) plays a crucial role in regulating B cell development and is associated with B cell malignancies. The complexity of IRF4 functions includes its involvement in different DNA-binding affinity, target motifs, and transcriptional partners.

CLINICAL AND EXPERIMENTAL MEDICINE (2023)

暂无数据